Suppr超能文献

人表面活性蛋白D的一种50千道尔顿的变体形式。

A 50-kDa variant form of human surfactant protein D.

作者信息

Mason R J, Nielsen L D, Kuroki Y, Matsuura E, Freed J H, Shannon J M

机构信息

Dept of Medicine, National Jewish Medical and Research Center, University of Colorado Health Sciences Center, Denver 80206, USA.

出版信息

Eur Respir J. 1998 Nov;12(5):1147-55. doi: 10.1183/09031936.98.12051147.

Abstract

The dominant form of human surfactant protein D (SP-D) is a multimeric collagenous glycoprotein composed of monomeric subunits that have a molecular mass of 43 kDa under reducing conditions. However, in evaluating monoclonal antibodies to human SP-D, an additional monomeric subunit was identified with a reduced molecular mass of 50 kDa. This 50-kDa variant was detected in approximately half of the samples evaluated and was found in lavage fluid from normal subjects, patients with alveolar proteinosis or idiopathic pulmonary fibrosis and in amniotic fluid. This 50-kDa variant had the same amino-terminal sequence, amino acid composition and apparent size of the carboxy-terminal collagenase-resistant fragment (20 kDa) as the 43-kDa subunit. The major difference was in the amino-terminal portion of the molecule and was due to altered glycosylation, as determined by carbohydrate staining, chemical deglycosylation, treatment with N-glycanase and neuraminidase and reduced signals for threonine at positions 5, 9 and 10 during amino-terminal sequencing. After gel filtration chromatography, the 50-kDa form was not present in the high molecular weight fraction, which is commonly used in purification of SP-D, but was found only in the smaller molecular weight fraction of monomers and trimers of SP-D. In conclusion, the 50 kDa-form of surfactant protein D is produced by post-translational glycosylation and does not form higher ordered oligomers, but its precise physiological function remains to be determined.

摘要

人表面活性蛋白D(SP-D)的主要形式是一种多聚体胶原糖蛋白,由单体亚基组成,在还原条件下其分子量为43 kDa。然而,在评估针对人SP-D的单克隆抗体时,发现了另一种分子量降低的单体亚基,为50 kDa。在大约一半的评估样本中检测到了这种50 kDa的变体,它存在于正常受试者、肺泡蛋白沉积症患者或特发性肺纤维化患者的灌洗液以及羊水中。这种50 kDa的变体与43 kDa亚基具有相同的氨基末端序列、氨基酸组成以及羧基末端抗胶原酶片段(20 kDa)的表观大小。主要差异在于分子的氨基末端部分,这是由于糖基化改变所致,通过碳水化合物染色、化学去糖基化、用N-糖苷酶和神经氨酸酶处理以及氨基末端测序过程中第5、9和10位苏氨酸信号减弱得以确定。经过凝胶过滤色谱分析后,50 kDa形式不存在于常用于纯化SP-D的高分子量组分中,而是仅存在于SP-D单体和三聚体的较小分子量组分中。总之,表面活性蛋白D的50 kDa形式是通过翻译后糖基化产生的,不形成更高阶的寡聚体,但其确切的生理功能仍有待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验